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Abstract
Background: Gene-set analysis (GSA) has been commonly used to identify significantly altered pathways or
functions from omics data. However, GSA often yields a long list of gene-sets, necessitating efficient post-
processing for improved interpretation. Existing methods cluster the gene-sets based on the extent of their overlap
to summarize the GSA results without considering interactions between gene-sets.
Results: Here, we presented a novel network-weighted gene-set clustering that incorporates both the gene-set
overlap and protein-protein interaction (PPI) networks. Three examples were demonstrated for microarray gene
expression, GWAS summary, and RNA-sequencing data to which different GSA methods were applied. These
examples as well as a global analysis show that the proposed method increases PPI densities and functional
relevance of the resulting clusters. Additionally, distinct properties of gene-set distance measures were compared.
The methods are implemented as an R/Shiny package GScluster that provides gene-set clustering and diverse
functions for visualization of gene-sets and PPI networks.
Conclusions: Network-weighted gene-set clustering provides functionally more relevant gene-set clusters and
related network analysis.
Keywords: Gene-set clustering, Gene-set analysis, Protein-protein interaction, Network
Background
Gene-set analysis (GSA) covers a broad category of
methods used to identify relevant biological pathways or
functions from omics data such as microarray or high
throughput sequencing data [1–4]. In many cases, GSA
yields tens to hundreds of significant gene-sets without
indicating how they interact with each other, rendering
it difficult to identify core pathways or functional
groups. Annotation databases such as Gene Ontology
and KEGG [5, 6] partially address this issue by providing
parent-offspring relations between annotation terms
when used for GSA. Other gene-set collections obtained
from independent and heterogeneous sources (e.g., gene
signatures in MSigDB [7]) even lack such partial
relations. Gene-set clustering, which helps identify the
organization of gene-sets and their biological themes,
has been used for improved interpretation of gene-sets.
For example, DAVID web server uses Cohen’s kappa dis-
tance, and Enrichment map uses Meet/Min distance to
cluster gene-sets into a number of subgroups [8–11].
However, these distance measures are only based on
gene counts in each gene-set category (e.g., overlap be-
tween two gene-sets) and may not fully reflect the
underlying biological relations such as protein-protein
interactions (PPIs) between gene-sets.
Once significant gene-sets are identified, these GSA
results can be further considered for a mechanistic
study. PPI networks related to these gene-sets can pro-
vide useful information for this purpose. However, most
GSA tools provide only the list of significant gene-sets
[1] or their own networks [12, 13] without visualizing
PPI networks between gene-sets. In this study, we
propose to use a network-weighted distance for cluster-
ing gene-sets and present an R/Shiny package, GScluster
(https://github.com/unistbig/GScluster), for clustering
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and network analysis of GSA results. The
network-weighted clustering was better able to capture
functionally relevant gene-set clusters compared with
existing gene-count-based methods in simulated and real
data analyses. GScluster accepts any GSA results from
external programs if a list of gene-sets and their member
genes (with or without gene-set scores) are provided.
A main goal of our analysis is to identify functionally
relevant gene-set clusters from a long list of gene-sets;
thus, the networks between genes (or proteins) in our
analysis can be any kind of functional interaction such
as gene co-expression, co-occurrence in the literature,
evolutionary distance, physical contact, or their combi-
nations, which were all simply denoted as PPI in this art-
icle. In GScluster, we adopted the STRING networks
that integrated seven different functional interaction
sources [14]. These networks also provide the widest
coverage of species and genes among currently available
network data (e.g., over 18,000 human genes). GScluster
also provides analysis based on HIPPIE 2.0 networks
[15] for human and customized network data.
To our knowledge, GScluster is the first attempt to in-
corporate both overlapping genes and PPI networks when
clustering gene-sets. DAVID and Enrichment Map neither
consider PPI networks during clustering gene-sets nor
visualize PPI networks for the clustered gene-sets. Because
both tools deploy different clustering strategies and DA-
VID only uses its own pathway gene-sets, a direct com-
parison between gene-set clustering results is not possible.
Therefore, in our comparative analysis, we applied the
same clustering strategy (fuzzy clustering) and compared
the clustering results for three different distance measures:
The Meet/Min distance of Enrichment Map (denoted as
MM), Cohen’s kappa distance used in DAVID (denoted as
KAPPA), and the PPI-weighted MM distance of GScluster
(denoted as pMM). We also note that fuzzy clustering
method allows a gene-set to belong to multiple clusters
and excludes isolated gene-sets.
Results
GScluster R package and GSAseq web server
We present two independent software tools: GScluster
(https://github.com/unistbig/GScluster) and GSAseq (http://
gsaseq.appex.kr). GSAseq is a web server for gene-set en-
richment analysis (GSEA) of RNA-sequencing (RNA-seq)
and microarray gene expression data [7] and is described in
Supplementary Material (Additional file 1) in detail. GSclus-
ter is an R/Shiny package for clustering and network analysis
of gene-sets. We place a major emphasis on GScluster for
its novelty and useful functions. GSEA and differential gene
expression results obtained from GSAseq can be directly
used for GScluster. Both software tools support analysis for
ten species including human, mouse, rat, fly, zebra fish, rice,
A. thaliana, worm, yeast, and E. coli. We note that GSA
result from our own tool for GWAS summary data is also
directly accepted by GScluster [16].
An overview of GScluster is shown in Fig. 1. The user
can also use a GSA result (and gene list) obtained from
other software tools for GScluster. The main input data
should have the columns of gene-set name, member
genes, gene-set score (e.g. FDR q-value), and optionally
the direction of each gene-set indicating up- or
down-regulation. GScluster additionally accepts data for
gene scores (e.g. differentially expressed (DE) genes) for
more focused analysis. GScluster implements the fuzzy
clustering [8] for the three set-distance measures (pMM,
MM, and KAPPA). GScluster is mainly built based on
Shiny and Cytoscape related R package (cyjShiny); thus
it provides interactive visualization of both gene-set and
PPI networks. Networks are visualized after gene-set
clustering is done. All the network figures and gene-set
clustering result table are downloadable as SVG and
CSV format, respectively. Detailed functions for network
visualization are described in Supplementary Material
(Additional file 1). GScluster clusters gene-sets and visu-
alizes networks in seconds to minutes, depending on the
size of input gene-set data (Fig. S1). The three example
datasets (GSA results) analyzed in this article are avail-
able in the GScluster package.
Network-weighted distance yields gene-set clusters with
denser network connections
Gene-set clustering aims at identifying groups of func-
tionally close gene-sets that can be characterized by sub-
stantial overlap and dense PPIs between gene-sets. Here,
we cluster the 3859 MSigDB C2 pathway sets [7, 17]
with sizes 10–200 using pMM, MM, and KAPPA dis-
tances, respectively, and compare the PPI densities of
resulting clusters. For each of the three distances, the
same upper 0.154% threshold (MM ≤ 0.5, pMM ≤ 0.384,
and KAPPA ≤ 0.727) was applied. Then, gene-set clus-
ters with similar sizes (number of genes included) are
compared between different methods. Because the sizes
of resulting clusters are not exactly matched between
methods, the trend lines between the cluster size and
average PPI score (STRING edge scores are normalized
to unit interval) in each cluster were compared (Fig. 2).
Here, gene pairs with no PPI received zero scores in cal-
culating the cluster averages, and a few outlier clusters
with more than 1000 genes were excluded (2, 3, and 1
clusters for MM, pMM, and KAPPA, respectively). As
expected, the average PPI scores tended to decrease as
the cluster size increases for all the three methods. In-
deed, the clusters obtained using pMM exhibited consid-
erably increased average PPI scores than those observed
using existing methods. For the clusters with less than
100 genes (39.8, 30.3, and 36.8% of pMM, MM, and
KAPPA clusters, respectively), the average PPI score of
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pMM clusters (0.30) was 20 and 50% higher than those
of MM (0.25) and KAPPA (0.20) clusters, respectively.
For the clusters containing 100–200 genes (36.4, 41.6,
and 31.6% of pMM, MM, and KAPPA clusters, respect-
ively), even higher rates of increase were observed (aver-
age PPI scores using pMM: 0.17, MM: 0.12, and KAPPA:
0.05). These results illustrate the effects of incorporating
PPI-networks in gene-set clustering, which can be con-
trolled by the balancing factor α. Simulation tests were
demonstrated in the next section to further compare the
features of different distance measures.
Gene-set clustering simulation
We designed three gene-set clusters as demonstrated in
Fig. 3a to compare the effects of different gene-set distances
on gene-set clustering. ‘n’ represents the number of genes
in a gene-set. The properties of each cluster were described
as follows:
1. Case 1: Ten gene-sets are largely classified into two
functionally distinct subgroups (left and right parts),
each composed of five gene-sets. The two sub-
groups share a substantial number of genes; how-
ever, PPIs are assigned only within each subgroup.
2. Case 2: Similar as Case 1 except that the two
subgroups share fewer genes and PPIs are assigned
only between the subgroups.
3. Case 3: A large gene-set (n = 200) includes five
small gene-sets (n = 10–15) that overlap with each
other.
Fig. 1 GScluster overview. Interactive network analysis is provided for both gene (protein) and gene-set networks
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Each case was simulated 500 times. The number of
total genes was fixed as 10,000. In Case 1 and 2, each
gene-set (n = 15–40) was sampled from either of two
pools of genes (denoted pool 1 and 2, respectively), each
with n = 60. These pools shared 20 genes. In Case 1, five
gene-sets for the first subgroup were sampled from pool
1, and the other five for the second subgroup from pool
2. Each gene-set in a subgroup has a counterpart
gene-set in the other subgroup and these gene-set pairs
have 45–50% of common genes. In Case 2, the gene-set
pairs had a lower proportion of overlap of (40–45%).
PPIs with scores of 0.15–0.99 were assigned to 40% of
gene (protein) pairs within each subgroup (Case 1), or
across the subgroups (Case 2). PPI scores were randomly
sampled from STRING networks and the resulting aver-
age PPI score for all gene pairs was 0.11. In Case 3, small
gene-sets were sampled from a common pool of 50
genes to generate overlap among them. In all cases, the
clustering cutoff of MM= 0.5 was used, and those for
the other two distances were determined based on the
corresponding percentile values in each dataset.
In Case 1, the two subgroups were merged into one
113 times out of 500 trials using MM. Among these, the
two subgroups were mostly separated when pMM was
used (89/113 times, 78.8%). In contrast, when KAPPA
was used, the two subgroups were separated only 11
times (9.7%) and still merged 77 times (68.2%); in the
remaining 25 cases (22.1%), ten gene-sets were imper-
fectly merged (Fig. 3b) which means some of the
gene-sets were not clustered. In Case 2, the two groups
were separated 156 times out of 500 trials using MM.
Among them, pMM mostly merged the two subgroups
(92/156 times, 59.0%) and separated them only 23/156
times (14.7%). In the remaining 41 cases (26.3%), the
two subgroups were imperfectly merged because the
missing gene-sets had relatively less number of PPIs with
the clusters (average PPI score within merged gene-sets:
0.355; average PPI score between merged and not
merged gene-sets: 0.249). KAPPA merged or separated
the two groups 30 (19.2%) and 82 times (52.6%), respect-
ively, and imperfect merging was observed 44 times
(28.2%) (Fig. 3c). These simulation results demonstrate
that pMM is capable of discriminating functionally dis-
tinct gene-set subgroups as represented by PPI net-
works. Small gene-sets were often missed from the
merged cluster when KAPPA was used, whereas pMM
did not show such a tendency (Fig. 3d).
Case 3 highlights the difference between KAPPA and
MM/pMM distances. KAPPA excluded the large super-
set (n = 200) and detected only the cluster of five small
gene-sets, whereas MM and pMM included the large
superset into a single large cluster as well. Given two
gene-sets, MM/pMM distances focused on the smaller
gene-set and assumed their distance was zero if one
gene-set was completely included by the other, irrespect-
ive of the size of the latter gene-set. By contrast, KAPPA
tended to cluster gene-sets with similar sizes. To dem-
onstrate the set-size dependence of KAPPA, a simple
simulation was devised. Suppose a set A has ten mem-
bers that are all contained in another set B. Then, KAPP
A between A and B was measured for varying sizes of B
(10–200). The size of B strongly affected the kappa dis-
tance (Fig. 3e), whereas MM distance was 0 irrespective
of the size of B.
Gene-set clustering/network analysis of real data
Complex diseases are caused by aberrant modulation of
multiple pathways. Thus, gene-set analysis of a complex
Fig. 2 Comparison of average PPI scores within clusters generated using each of three distance scores. All of the MSigDB C2 pathways satisfying a set
size criterion 10–200 were clustered using each of pMM, MM, and KAPPA distances. The average PPI scores (STRING) within each cluster were plotted
for the numbers of proteins in clusters. For each method, the 1st order trend lines are represented (MM: black triangle, pMM: red cross. KAPPA: blue X)
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disease often yields a long list of significant pathways,
making it difficult to identify core themes and overall
relations among the pathways. Here, we demonstrate
the network analysis of gene-sets using GScluster for
three datasets of complex diseases: Colorectal cancer
(CRC), type 2 diabetes (T2D), and acute myeloid
leukemia (AML). These datasets have different data
types (gene expression microarray, GWAS summary,
and RNA-seq) and were analyzed using different GSA
methods (GSEA, empirical self-contained GSA, and
adaptive Gene Ontology (GO) analysis). In each ex-
ample, clustering results based on pMM, MM, and
KAPPA were compared, and PPI networks in gene-set
clusters were analyzed. Only gene-sets with between
10 and 200 genes were analyzed.
GSEA of gene expression microarray data (colorectal cancer)
Microarray gene expression data (GSE4107) comprising 12
early onset CRC samples and 10 healthy controls were ana-
lyzed [18]. Differential expression analysis was performed
using limma R package [19], and gene-permuting GSEA
(gene score: log fold-change) was performed using GSAseq
and MSigDB curated gene-sets (C2 category) [7]. The ana-
lysis results were then input into GScluster. In total, 484
enriched gene-sets (false discovery rate (FDR) < 0.01) and




Fig. 3 Simulation of gene-set clustering. a Three models for gene-set clusters. Dots represent genes and circles represent gene-sets. First model
(Case 1) assumes that two subgroups (orange and sky-blue) are merged using MM distance but contain dense PPIs within each subgroup.
Second model (Case 2) represents two subgroups having insufficient overlap to be merged using MM score, but containing dense PPIs across
the subgroups. In the first and second models, only three gene-sets (instead of five) were represented in each subgroup to simplify the figures. In
third model (Case 3), a large gene-set contains multiple small gene-sets having overlaps. Black and gray dots represent genes included in gene-
set and background, respectively. Lines represent PPIs between genes. Clustering results for (b) Case 1 and (c) Case 2 are shown. Ratios in the y
axes indicate the successful detection ratios. Results for Case 3 was not shown because all trials showed the same result for each distance
measure (See the text). d Rank distributions of gene-set sizes of unclustered gene-sets in the imperfectly merged instances in Case 2. e A
simulation for KAPPA where set A (n = 10) is contained in another set B (n = 10–200). KAPPA is strongly affected by the set-size
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Figure 4a shows the gene-set clusters and networks gener-
ated using pMM. Each cluster contained gene-sets related to
cancer such as cellular respiration (TCA cycle; electron
transport chain pathways) [20, 21], fatty acid metabolism
[22], immune response [23], cell cycle and apoptosis [24, 25],
growth factor [26], and hypoxia [27, 28].
Fuzzy clustering of the 484 significant gene-sets gener-
ated 11, 10, and 14 clusters using MM, pMM, and
KAPPA, respectively (Additional file 2: Supplementary
Table S1). Overall, the three distances resulted in similar
clusters; however, some clusters revealed distinctive fea-
tures of each distance, as demonstrated in the simulation
test. For example, ‘fatty acid metabolism’ cluster included
six related terms using MM (e.g., KEGG fatty acid me-
tabolism and Reactome mitochondrial fatty acid beta
oxidation). pMM extended this cluster with three add-
itional terms related to short chain fatty acids (KEGG
propanoate metabolism and KEGG butanoate metabol-
ism) and vascular fatty acid transport (Reactome
branched chain amino acid catabolism). Their additions
were ascribed to the PPI weights; the average PPI score
between the six and the additional three pathways was
0.106 which was 7.54 times higher than that of back-




Fig. 4 Gene-set network analysis of early-onset colorectal cancer data. a Gene-set networks/clusters obtained using pMM (GSEA FDR < 0.01). Pink and
green nodes represent up- or down-regulation of gene-sets, respectively. Overlapping clusters were represented by dashed circles. The cluster labels
were manually written by the authors. The sizes of node and gene-set name are adjustable on the web. b Gene-set clusters of fatty acid metabolism
derived from pMM, MM, and KAPPA, respectively. In the pMM cluster, nodes bordered by orange and blue boxes indicate gene-sets that were not
included in the MM and KAPPA cluster, respectively. c PPI network (score≥ 0.5) of significant genes (FDR < 0.01) in cellular respiration cluster. SDHB
was the hub (degree = 25). d PPI networks connected with SDHB in cellular respiration cluster. Met represents Metabolism
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significant gene-sets. Compared with the pMM results,
KAPPA removed the largest pathway (Reactome fatty acid
triacylglycerol and ketone body metabolism, n = 145) and
its small subset (Sanderson PPARa targets, n = 15) pos-
sibly because of the set-size differences.
‘Immune response’ cluster showed a similar pattern. It
contained 15 gene-sets related to lymphocyte activation
using MM (e.g., Biocarta TCR pathway, Biocarta
T-helper pathway, Reactome CXCR4 pathway). pMM in-
cluded three additional relevant pathways (‘Biocarta T
cytotoxic pathway’, ‘Lee differentiating T lymphocyte’, and
‘Vilimas Notch1 targets up’) in this cluster. The average
PPI score between the 15 MM pathways and three add-
itional pathways were 0.041 which was 2.93 times higher
than that of the background. Among the 18 gene-sets in
the pMM immune cluster, KAPPA was only able to clus-
ter eight small immune response gene-sets (n = 11–25).
We then analyzed an extended list of 1147 gene-sets
obtained from a larger threshold FDR < 0.1. Clustering
using pMM yielded a large cluster related to ‘cell sur-
vival, proliferation, and differentiation’ (N = 67; N repre-
sents the number of gene-sets in a cluster, see in
Additional file 1: Figure S2a ). In this cluster was found
an important pathway in cancer, ‘Reactome activation of
the AP1 family of transcription factors’. This pathway
was the most highly connected (degree = 29) among the
entire list of gene-sets in the pMM gene-set networks.
This result is very relevant, because AP-1 is a well-known
key transcriptional regulator for cell survival, proliferation,
and differentiation in cancer [29, 30], and its activation
pathway is connected to many related cell signaling path-
ways. In contrast, using MM or KAPPA, this gene-set was
not detected as a hub and was connected to only a small
number of gene-sets (MM: seven sets, KAPPA: three sets,
see in Additional file 1: Figure S2b). We note that the
gene-set clustering results for different distance measures
have similar numbers of edges between gene-sets (pMM:
1242; MM: 1112; KAPPA: 1252) because the same per-
centile cutoff values were applied. Therefore, this example
reveals a critical difference in the network structures with
or without PPI weights.
GScluster enables to explore the PPI networks within
each cluster, and easily identify the hub genes and their
neighbors. For example, a cluster of ‘cellular respiration’
contained 11 gene-sets related to TCA cycle and oxidative
phosphorylation. These gene-sets were down-regulated in
colorectal cancer because of the Warburg effect that can-
cer cells exploit aerobic glycolysis rather than oxidative
phosphorylation to produce energy [31]. The PPI network
of this cluster contained 66 genes (PPI score ≥ 0.5).
Among them, succinate dehydrogenase B (SDHB), partici-
pating in both citric acid cycle and respiratory chain [32],
was the hub having connections with 25 genes. Deficiency
of this gene increases cancer cell migration and invasion
by activating the transforming growth factor (TGF) beta
signaling pathway [33, 34]. Figure 4c, d represent the PPI
networks of SDHB in this cluster.
Self-contained GSA of GWAS summary data (type 2
diabetes mellitus)
Next, stage 1 GWAS summary statistic data provided
from the DIAGRAM consortium were analyzed [35].
This dataset was obtained from a meta-analysis compar-
ing genotypes of 12,171 patients with T2D and 56,862
controls collected from 12 GWAS European popula-
tions. For this dataset, a recently developed empirical
self-contained GSA method, called sARTP was applied
using ARTP2 R package [36]. In addition, gene p-values
were calculated using VEGAS2 tool [37]. sARTP method
detected 193 significant gene-sets out of 1264 MSigDB
C2 canonical pathways (FDR < 0.25). Fuzzy clustering
summarized these sets into 12, 10, and 16 clusters using
pMM, MM, and KAPPA, respectively (Additional file 2:
Supplementary Table S2). Many clusters included
gene-sets that were closely related to T2D such as beta
cell regulation [38], unfolded protein response [39],
Notch/Wnt/PS1 signaling [40], cell cycle [41, 42], signal
transduction [43, 44], cancer [45], voltage-gated potas-
sium channel [46, 47], immune response [48], and lipid
metabolism [49]. The gene-set networks generated using
pMM are shown in Fig. 5a.
Some of the clusters clearly revealed specific features
of each distance measure as observed in the simulation
test. For example, ‘lipid metabolism’ cluster corre-
sponded to Case 1 and 3 in the simulation. Among the
MM clustering results, a cluster included two distinct
functions, phospholipid and triglyceride related terms
(N = 11). It was ascribed to the overlap of a triglyceride
term (Reactome triglyceride biosynthesis) with three
phospholipid terms (Reactome synthesis of PA, Reac-
tome glycerophospholipid biosynthesis, and Reactome
phospholipid metabolism) (MM= 0.48–0.5). The 14
overlapping genes were general synthesis related genes
(e.g., AGPAT/GPAT family, GPAM, and GPD1) that are
involved in both triglyceride and phospholipid biosyn-
thesis [50]. In contrast, pMM yielded two separate clusters
of ‘phospholipid’ (N = 5) and ‘triglyceride metabolism’
(N = 6). Such different cluster structures were clearly
caused by the PPI distribution; the average PPI score be-
tween the two clusters was even lower than that of the
background (0.016, odds ratio = 0.496), whereas the aver-
age PPI scores within each cluster were much higher
(phospholipid: 0.21, odds ratio = 8.39; triglyceride: 0.099,
odds ratio = 3.46). This separation of clusters is also bio-
logically reasonable because they represent clearly distinct
functions; phospholipids are structural constituent of cell
membranes, whereas triglycerides are used for energy
storage [50].
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Figure 5c shows the PPI network of ‘innate immune
response’ cluster containing 31 gene-sets. It exhibited
dense connections among ten well-known immune re-
lated genes (gene p-value < 0.01). In particular, four hub
genes (NFKB1, NFKB2, TNF, and TP53) were completely
connected to each other. The roles of these genes in
T2D have been well-studied. Expressions of these
pro-inflammatory genes are usually elevated in T2D.
These are activated under obesity or high-fat diet condi-
tions and cause an inflammatory response that leads to
insulin resistance [51–53]. Besides, TP53 was also de-
tected as a hub in another cluster related to cancer/cell
cycle and cell signaling pathways. This cluster included
many gene-sets altered in both cancer and diabetes such
as cell cycle, Akt pathway, and MAPK pathway. It was
reported that a dysregulated isoform of TP53 (Δ40p53)
causes cell cycle arrest in beta cells and insulin resist-
ance [54].
GO analysis of RNA-seq data (acute myeloid lymphoma)
Lastly, GO analysis was performed for RNA-seq data com-
posed of induced pluripotent stem cells derived from three
patients with AML and three healthy controls [55]. In total,
5307 DE genes were identified out of 21,441 genes (FDR <
0.01 and two or larger fold change) using DESeq2 [56]. GO
analysis was performed for these genes using GOseq R
package [57]. GOseq is specifically designed for GO analysis
of RNA-seq data to address the read count bias (or gene
length bias) in DE analysis of RNA-seq data [58, 59].
Among 5136 MSigDB C5 gene-sets, GOseq yielded 86 sig-
nificant gene-sets (FDR < 0.01).
(a) (b)
(c)
Fig. 5 Gene-set network analysis of Type 2 Diabetes. a Gene-set networks/clusters obtained using pMM (sARTP FDR < 0.25). Overlapping clusters
are represented using dashed circles. The cluster labels are manually written by the authors. UPR means unfolded protein response. b Clusters of
lipid metabolism derived by MM (left) and KAPPA (right). Whereas pMM separated triglyceride (fat) and phospholipid metabolism pathways, MM
and KAPPA distance combined them into one cluster. Also, KAPPA added another gene-set in the cluster. Green and pink border represent the
gene-sets related to phospholipid and fat metabolism, respectively. TG means Triglyceride. c PPI network (PPI score≥ 0.5) of significant genes
(FDR < 0.01) in the immune cluster. NFKB1, NFKB2, TNF, and TP53 were fully connected to each other
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Fuzzy clustering of these gene-sets yielded 15, 11, and 19
clusters using pMM, MM, and KAPPA, respectively (Add-
itional file 2: Supplementary Table S3). These clusters sum-
marized the characteristic pathways of AML, such as
immune response [60, 61], synapse [62], anchored compo-
nent of membrane (e.g., CD48, CD56) [63, 64], neuropeptide
[65, 66], tyrosine kinase [67], developmental [68, 69], blood
pressure regulation [70, 71], cyclic nucleotide [72, 73],
voltage-gated ion channels [74, 75] and phospholipase C
[76] (Fig. 6a).
Among the eleven clusters produced using MM, only
one was different from those generated using pMM. It
contained 94 gene-sets and the majority (77%) of them
were related to the development of kidney, cartilage, car-
diovascular system, and nervous system. Other sets were
related to leukocyte chemotaxis and migration (LCM),
protein tyrosine kinase (TK), phospholipase C (PC), and
phosphatidylinositol (PI) regulation. When pMM was
applied, these distinct sets were separated from the large
cluster. The average PPI within each separated cluster
was much higher than that of combined one (Average
PPI: combined = 0.036, LCM = 0.073, TK = 0.113, PC =
0.132, PI = 0.149).
Clusters produced using KAPPA were quite different
from those obtained using MM and pMM. For example,
MM and pMM produced two distinct clusters of blood
pressure regulation (N = 12) and voltage-gated ion chan-
nel (N = 18). Using KAPPA these clusters were com-
bined into one with additional three gene-sets which
worked as ‘mediators’ between the two clusters (Fig. 6b).
(a)
(b)
Fig. 6 Gene-set network analysis of acute myeloid leukemia. a Gene-set networks/clusters obtained using pMM (GOseq FDR < 0.01). In this case,
the nodes are colored in blue because GOseq results do not give the information of up- or down-regulation. The labels of clusters were manually
added by the author. b An example KAPPA gene-set cluster. This cluster combined ‘voltage-gated ion channel’ and ‘blood pressure regulation’
clusters with connecting gene-sets (denoted by arrows)
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The gene-set ‘heart process’ (n = 85) had no connection
with the gene-sets in the voltage-gated ion channel clus-
ter using MM or pMM. However, KAPPA connected it
with three sets in this cluster (‘multicellular organismal
signaling’ (n = 123), ‘cardiac conduction’ (n = 82) and ‘ac-
tion potential’ (n = 94)) because of the similar gene-set
sizes. Also, it was connected to ‘regulation of muscle
contraction’ (n = 147) which was linked to a gene-set in
the blood pressure cluster (‘positive regulation of blood
circulation’ (n = 93)) only by KAPPA. In the large com-
bined cluster, a small pathway ‘vasodilation’ (n = 26) was
removed because it lost the link with its superset ‘vascu-
lar process in circulatory system’ (n = 163) using KAPPA
because of the size difference.
Discussion
Gene-set analysis often yields a long list of gene-sets. DA-
VID [8] or Enrichment Map [11] cluster those gene-sets
to summarize the results and identify core themes regard-
ing the phenotype of interest. However, these methods
only consider ‘overlap’ based distances in clustering
gene-sets, whereas functionally related gene-sets usually
share a number of PPIs as well as some genes.
In the present study, we introduced a PPI-weighted
gene-set distance (pMM) that incorporates both the
overlapping genes and PPIs between two gene-sets.
pMM was compared with existing distance measures,
Meet/Min (MM) and kappa distance, in clustering a
large collection of gene-sets (MSigDB C2), where pMM
clusters, as expected, exhibited systematically higher PPI
densities than those obtained using MM or KAPPA
distances. pMM enabled to capture biologically more
meaningful clusters as shown in three analysis examples.
We also presented GScluster tool for clustering and net-
work analysis of gene-sets. It accepts any kind of GSA
results and helps to identify core biological themes from
a long list of gene-sets.
Additionally, the unique properties of each distance
measure were demonstrated from simulation and real
data analysis. In particular, kappa distance used in DA-
VID was highly sensitive to gene-set size difference and
tended to cluster gene-sets of similar sizes. This property
of kappa distance should be taken into account when
clustering the hierarchically organized gene-sets in GO
and KEGG, because kappa distance may not cluster a
large general pathway and its small sub-pathways.
In the colon cancer example, only the pMM-based
clustering identified the well-known oncogenic com-
plex, AP1 family pathway as hub gene-set. In the T2D
example, two unrelated pathway groups (phospholipid
and triglyceride synthesis) were clustered into one
when the overlap-based distance (MM) was used,
because they shared general synthesis-related genes.
However, these two pathways have distinct functions
and should not be taken together just because they
share some non-specific genes. pMM reflected the rela-
tively dense PPI scores within each group and success-
fully separated them into two distinct pathway groups.
These examples as well as the simulation results indi-
cate that PPIs should be taken into account for gene-set
clustering and network analysis. Whereas the default
network weighting of α = 1 worked well for STRING
networks in all the three examples in this paper, this fac-
tor could be reduced if the network data are of low qual-
ity or less reliable. By incorporating PPI networks,
GScluster provided functionally more relevant gene-set
clusters as well as corresponding PPI networks. Because
gene-set clusters can be regarded as ‘extended’ pathways,
PPIs in each cluster can provide useful insights for fur-
ther study. In particular, GScluster showed that some
proteins are hubs in multiple clusters, suggesting their
multifaceted roles in diseases.
In clustering gene-sets, we implemented fuzzy cluster-
ing in GScluster package. This method has several ad-
vantages in summarizing a long list of gene-sets. First, it
generates compact type clusters. Spectral clustering [77],
for example, focuses more on the connectivity between
nodes; thus, some pairs of nodes in a cluster can have
very large distances. Second, the number of clusters is
adaptively determined from the gene-set distance cutoff.
Spectral clustering and k-medoids require a predeter-
mined number of clusters which is not known to the
user. Lastly, fuzzy clustering allows a gene-set to belong
to two or more clusters. This flexibility is important be-
cause some gene-sets have important roles in multiple
pathways. In contrast, many other clustering methods
simply partition the gene-sets.
In addition to gene-set clustering, we expect that
the PPI-weighted set distance (pMM) can also be
used to design an enrichment analysis method (or
GO analysis). Enrichment analysis typically evaluates
enrichment of a test gene-set (e.g., DE genes from an
experiment) in each pre-defined gene-set based on
their overlap, whereas recent ‘network enrichment’
analysis methods consider enrichment of networks be-
tween gene-sets. pMM suggests a way to combine
overlap and networks in enrichment analysis.
Conclusions
Gene-set clustering has been widely used to summarized
a long list of gene-sets. Here, we demonstrated that our
PPI-network weighted gene-set distance yields biologic-
ally more relevant gene-set clusters by simulated and
real data analysis. We also provided GScluster R/Shiny
package for PPI-weighted gene-set clustering and net-
work visualization.
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Methods
Gene-set clustering and distance measures
The distance matrix between gene-sets are calculated
using Meet/Min, PPI-weighted Meet/Min or Cohen’s
kappa distance, and the fuzzy clustering algorithm
used in DAVID was implemented in GScluster [8].
The distance measures used are described as follows:
(1) Meet/Min distance (MM) for two gene-sets A and B:
MM A;Bð Þ ¼ 1− A⋂Bj j
min Aj j; Bj jð Þ
where |A| is size of A.
(2) PPI-weighted Meet/Min (pMM) distance: For two
gene-sets A and B,
pMM A→Bð Þ ¼ 1− A⋂Bj j
min Aj j; Bj jð Þ
−
α





y∈A∩BP x; yð Þ þ
P
y∈B−AP x; yð Þ
max Pð Þ∙ w A∩Bj j þ B−Aj jð Þ
ð1Þ
where P is the PPI score matrix, P(x, y) is the PPI
score of two genes x and y, α∈ [0, 1] is the balancing
factor (default α = 1) used to control the network
weighting based on quality or importance of the
network data, and w ¼
jAj





pMM(B→A) is symmetrically defined. Then, the dis-
tance between A and B is defined as
pMM A;Bð Þ ¼ min pMM A→Bð Þ; pMM B→Að Þð Þ:
The last term in (1) represents the overall PPI score
between genes x ∈A − B and y ∈ B. This term is
designed as follows: if x ∈A − B is fully connected
with all the members in B with the maximum PPI
score, this gene is regarded as one more overlap
between A and B from the perspective of MM score.
If y ∈A ∩ B, the interaction score is down-weighted by
w because the interaction in this case can be ambigu-
ously regarded as that either within A or between A
and B. This weight is determined by the probability
that y belongs to the opposite set. For example, if
|A| ≤ ∣ B∣, y is assumed to more likely belong to A;
therefore the probability of y to belong to B becomes
1=jBj
1=jAjþ1=jBj ¼ jAjjAjþjBj . Although the PPI weighting has
substantial effects on gene-set clustering, it also im-
plies that effects of ‘hub’ genes with many strong
connections with the opposite set are reasonably con-
trolled. In general, pMM is less than or equal to
MM, and they have the same value if there are no
PPIs between two gene-sets. Because gene-set cluster
structures are determined by the relative distances be-
tween gene-sets, some clusters can be dramatically
changed by incorporating the PPI-weighted distance.
Figure 7 illustrates how to calculate pMM between
two gene-sets.
(3) kappa distance (KAPPA): Cohen’s kappa distance
considers the background genes (A∪ B)C as well
and is defined as:
Fig. 7 PPI-weighted gene-set distance. Two gene-sets A and B contain 10 and 20 genes, respectively, and share six genes. Red lines indicate PPIs
between A-B and B-A, and blue lines, PPIs between A-B and A ∩ B. Here, all the PPI scores are simply assumed to be 1. Right table shows how to
calculate pMM distance, and compares with MM distance value
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KAPPA A;Bð Þ ¼ 1−O−E
1−E
where O ¼ jA∩BjþjðA∪BÞcjjUj and E ¼ jAj∙jBjþjA
cj∙jBcj
jUj2 are the ob-
served and expected agreement rates of two gene-sets,
respectively, and U is the set of all genes.
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